By Juliet Williams (Kymera Therapeutics)2024-07-23T10:00:22
As part of our series highlighting women in STEM, we spoke to Juliet Williams, Head of Research at Kymera. She discusses what inspired her early passion for science, the power of mentorship and what excites her most about the future of targeted protein degradation – and its potential to deliver ...
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2023-06-13T13:30:40
Sponsored by NanoTemper Technologies
2023-11-20T13:43:43
Sponsored by Merck
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud